These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17576816)

  • 1. A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor.
    Chan MC; Nguyen PH; Davis BN; Ohoka N; Hayashi H; Du K; Lagna G; Hata A
    Mol Cell Biol; 2007 Aug; 27(16):5776-89. PubMed ID: 17576816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells.
    Yu PB; Deng DY; Beppu H; Hong CC; Lai C; Hoyng SA; Kawai N; Bloch KD
    J Biol Chem; 2008 Feb; 283(7):3877-88. PubMed ID: 18042551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells.
    Lagna G; Nguyen PH; Ni W; Hata A
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L1059-67. PubMed ID: 17030903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
    Yu PB; Beppu H; Kawai N; Li E; Bloch KD
    J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
    Xia Y; Yu PB; Sidis Y; Beppu H; Bloch KD; Schneyer AL; Lin HY
    J Biol Chem; 2007 Jun; 282(25):18129-18140. PubMed ID: 17472960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins.
    Ahmed S; Metpally RP; Sangadala S; Reddy BV
    J Mol Graph Model; 2010 Apr; 28(7):670-82. PubMed ID: 20137990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1.
    Foletta VC; Lim MA; Soosairajah J; Kelly AP; Stanley EG; Shannon M; He W; Das S; Massague J; Bernard O
    J Cell Biol; 2003 Sep; 162(6):1089-98. PubMed ID: 12963706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
    Zhu H; Kavsak P; Abdollah S; Wrana JL; Thomsen GH
    Nature; 1999 Aug; 400(6745):687-93. PubMed ID: 10458166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein 2 inhibits neurite outgrowth of motor neuron-like NSC-34 cells and up-regulates its type II receptor.
    Benavente F; Pinto C; Parada M; Henríquez JP; Osses N
    J Neurochem; 2012 Aug; 122(3):594-604. PubMed ID: 22612292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis.
    Lee-Hoeflich ST; Causing CG; Podkowa M; Zhao X; Wrana JL; Attisano L
    EMBO J; 2004 Dec; 23(24):4792-801. PubMed ID: 15538389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of translation and endocytosis of alternatively spliced forms of the type II bone morphogenetic protein (BMP) receptor.
    Amsalem AR; Marom B; Shapira KE; Hirschhorn T; Preisler L; Paarmann P; Knaus P; Henis YI; Ehrlich M
    Mol Biol Cell; 2016 Feb; 27(4):716-30. PubMed ID: 26739752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
    Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
    Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP-2 and -4 produced by vascular smooth muscle cells from atherosclerotic lesions induce monocyte chemotaxis through direct BMPRII activation.
    Simões Sato AY; Bub GL; Campos AH
    Atherosclerosis; 2014 Jul; 235(1):45-55. PubMed ID: 24814649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II.
    Kudo TA; Kanetaka H; Watanabe A; Okumoto A; Asano M; Zhang Y; Zhao F; Kano M; Shimizu Y; Tamura S; Hayashi H
    Tohoku J Exp Med; 2010 Oct; 222(2):121-9. PubMed ID: 20919447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.